Share
Journal Information
Most cited
Data available in articles published since the year 2014
208
Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysisR. Torres-Castro, L. Vasconcello-Castillo, X. Alsina-Restoy, L. Solis-Navarro, F. Burgos, H. Puppo, J. Vilaró
Pulmonol. 2021;27:328-37
208
Open access
Open Article
157
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohortsI. Motta, R. Centis, L. D’Ambrosio, J.-M. García-García, D. Goletti, G. Gualano, F. Lipani, F. Palmieri, A. Sánchez-Montalvá, E. Pontali, G. Sotgiu, A. Spanevello, C. Stochino, E. Tabernero, M. Tadolini, M. van den Boom, S. Villa, D. Visca, G.B. Migliori
Pulmonol. 2020;26:233-40
157
Open access
156
Evaluating the massive underreporting and undertesting of COVID-19 cases in multiple global epicentersH. Lau, T. Khosrawipour, P. Kocbach, H. Ichii, J. Bania, V. Khosrawipour
Pulmonol. 2021;27:110-5
156
Open access
136
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effectsD. Visca, C.W.M. Ong, S. Tiberi, R. Centis, L. D’Ambrosio, B. Chen, J. Mueller, P. Mueller, R. Duarte, M. Dalcolmo, G. Sotgiu, G.B. Migliori, D. Goletti
Pulmonol. 2021;27:151-65
136
Open access
Open Article
128
Medical masks and Respirators for the Protection of Healthcare Workers from SARS-CoV-2 and other virusesMariachiara Ippolito, Filippo Vitale, Giuseppe Accurso, Pasquale Iozzo, Cesare Gregoretti, Antonino Giarratano, Andrea Cortegiani
Pulmonol. 2020;26:204-12
128
Open access
118
Tuberculosis, social determinants and co-morbidities (including HIV)R. Duarte, K. Lönnroth, C. Carvalho, F. Lima, A.C.C. Carvalho, M. Muñoz-Torrico, R. Centis
Pulmonol. 2018;24:115-9
118
Open access
110
New drugs and perspectives for new anti-tuberculosis regimensS. Tiberi, M. Muñoz-Torrico, R. Duarte, M. Dalcolmo, L. D’Ambrosio, G.-B. Migliori
Pulmonol. 2018;24:86-98
110
Open access
101
COVID-19 pandemic and non invasive respiratory management: Every Goliath needs a David. An evidence based evaluation of problemsJ.C. Winck, N. Ambrosino
Pulmonol. 2020;26:213-20
101
Open access
98
Rationale and evidence on the use of tocilizumab in COVID-19: a systematic reviewA. Cortegiani, M. Ippolito, M. Greco, V. Granone, A. Protti, C. Gregoretti, A. Giarratano, S. Einav, M. Cecconi
Pulmonol. 2021;27:52-66
98
Open access
Open Article
82
The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectivesJ.L. Boechat, I. Chora, A. Morais, L. Delgado
Pulmonol. 2021;27:423-37
82
Open access
Special content about COVID-19
- A Different Wave – Posttraumatic Stress Disorder among healthcare professionals during the COVID-19 pandemic
- COVID-19 pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU. Author's reply
- Intermittent versus equivalent constant-load cycle training in COVID-19 patients
- Impact of the COVID-19 pandemic on in-hospital diagnosis of tuberculosis in non-HIV patients
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
